Authors:
MINSHALL RD
STANCZYK FZ
MIYAGAWA K
UCHIDA B
AXTHELM M
NOVY M
HERMSMEYER K
Citation: Rd. Minshall et al., OVARIAN-STEROID PROTECTION AGAINST CORONARY-ARTERY HYPERREACTIVITY INRHESUS-MONKEYS, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 649-659
Citation: C. Coulam et al., ALTERED BALANCE BETWEEN THE 5-ALPHA-REDUCTASE AND AROMATASE PATHWAYS DURING OVARIAN STIMULATION WITH HMG, Fertility and sterility, 69(3), 1998, pp. 6-6
Citation: Mm. Cho et al., THE OVARIAN CONTRIBUTION TO SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR DURING STIMULATED CYCLES, Fertility and sterility, 69(3), 1998, pp. 15-15
Authors:
BELLO SM
GRAY JD
NAVIDAZEH N
GENTZSCHEIN E
COULAM C
SHOUPE D
STANCZYK FZ
Citation: Sm. Bello et al., EFFECTS OF ORAL AND TRANSDERMAL ESTRADIOL ON THE GROWTH HORMONE IGF-1AXIS IN RELATION TO THE IMMUNE-SYSTEM/, Fertility and sterility, 69(3), 1998, pp. 31-31
Authors:
FEIGELSON HS
SHAMES LS
PIKE MC
COETZEE GA
STANCZYK FZ
HENDERSON BE
Citation: Hs. Feigelson et al., CYTOCHROME P450C17-ALPHA GENE (CYP17) POLYMORPHISM IS ASSOCIATED WITHSERUM ESTROGEN AND PROGESTERONE CONCENTRATIONS, Cancer research, 58(4), 1998, pp. 585-587
Authors:
ROSS RK
PIKE MC
COETZEE GA
REICHARDT JKV
MIMI CY
FEIGELSON H
STANCZYK FZ
KOLONEL LN
HENDERSON BE
Citation: Rk. Ross et al., ANDROGEN METABOLISM AND PROSTATE-CANCER - ESTABLISHING A MODEL OF GENETIC SUSCEPTIBILITY, Cancer research, 58(20), 1998, pp. 4497-4504
Authors:
COTE RJ
SKINNER EC
SALEM CE
MERTES SJ
STANCZYK FZ
HENDERSON BE
PIKE MC
ROSS RK
Citation: Rj. Cote et al., THE EFFECT OF FINASTERIDE ON THE PROSTATE-GLAND IN MEN WITH ELEVATED SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS, British Journal of Cancer, 78(3), 1998, pp. 413-418
Authors:
DORGAN JF
STANCZYK FZ
LONGCOPE C
STEPHENSON HE
CHANG L
MILLER R
FRANZ C
FALK RT
KAHLE L
Citation: Jf. Dorgan et al., RELATIONSHIP OF SERUM DEHYDROEPIANDROSTERONE (DHEA), DHEA SULFATE, AND 5-ANDROSTENE-3-BETA,17-BETA-DIOL TO RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN, Cancer epidemiology, biomarkers & prevention, 6(3), 1997, pp. 177-181
Authors:
VATTEN LJ
URSIN G
ROSS RK
STANCZYK FZ
LOBO RA
HARVEI S
JELLUM E
Citation: Lj. Vatten et al., ANDROGENS IN SERUM AND THE RISK OF PROSTATE-CANCER - A NESTED CASE-CONTROL STUDY FROM THE JANUS SERUM BANK IN NORWAY, Cancer epidemiology, biomarkers & prevention, 6(11), 1997, pp. 967-969
Authors:
GUESS HA
FRIEDMAN GD
SADLER MC
STANCZYK FZ
VOGELMAN JH
IMPERATOMCGINLEY J
LOBO RA
ORENTREICH N
Citation: Ha. Guess et al., 5-ALPHA-REDUCTASE ACTIVITY AND PROSTATE-CANCER - A CASE-CONTROL STUDYUSING STORED SERA, Cancer epidemiology, biomarkers & prevention, 6(1), 1997, pp. 21-24
Authors:
CARMINA E
WONG L
CHANG L
PAULSON RJ
SAUER MV
STANCZYK FZ
LOBO RA
Citation: E. Carmina et al., ENDOCRINE ABNORMALITIES IN OVULATORY WOMEN WITH POLYCYSTIC OVARIES ONULTRASOUND, Human reproduction, 12(5), 1997, pp. 905-909
Authors:
STANCZYK FZ
PATEL S
MISTRY J
RANADIVE G
SAVJANI G
PAULSON RJ
Citation: Fz. Stanczyk et al., DISCREPANCY IN THE CORRELATION BETWEEN CIRCULATING ESTRONE SULFATE AND ESTRADIOL CONCENTRATIONS DURING OVARIAN HYPERSTIMULATION AND EXOGENOUS ESTROGEN ADMINISTRATION IN WOMEN, Human reproduction, 12, 1997, pp. 233-233
Authors:
URSIN G
LONDON S
STANCZYK FZ
GENTZSCHEIN E
PAGANINIHILL A
ROSS RK
PIKE MC
Citation: G. Ursin et al., A PILOT-STUDY OF URINARY ESTROGEN METABOLITES (16-ALPHA-OHE1 AND 2-OHE1) IN POSTMENOPAUSAL WOMEN WITH AND WITHOUT BREAST-CANCER, Environmental health perspectives, 105, 1997, pp. 601-605
Authors:
STANCZYK FZ
GENTZSCHEIN E
ARY BA
KOJIMA T
ZIOGAS A
LOBO RA
Citation: Fz. Stanczyk et al., URINARY PROGESTERONE AND PREGNANEDIOL - USE FOR MONITORING PROGESTERONE TREATMENT, Journal of reproductive medicine, 42(4), 1997, pp. 216-222
Authors:
WILCOX JG
HATCH IE
GENTZSCHEIN E
STANCZYK FZ
LOBO RA
Citation: Jg. Wilcox et al., ENDOTHELIN LEVELS DECREASE AFTER ORAL AND NONORAL ESTROGEN IN POSTMENOPAUSAL WOMEN WITH INCREASED CARDIOVASCULAR RISK-FACTORS, Fertility and sterility, 67(2), 1997, pp. 273-277
Authors:
WILCOX JG
HWANG H
HODIS HN
SEVANIAN A
STANCZYK FZ
LOBO RA
Citation: Jg. Wilcox et al., CARDIOPROTECTIVE EFFECTS OF INDIVIDUAL CONJUGATED EQUINE ESTROGENS THROUGH THEIR POSSIBLE MODULATION OF INSULIN-RESISTANCE AND OXIDATION OFLOW-DENSITY-LIPOPROTEIN, Fertility and sterility, 67(1), 1997, pp. 57-62
Citation: Fz. Stanczyk, PHARMACOKINETICS OF THE NEW PROGESTOGENS AND INFLUENCE OF GESTODENE AND DESOGESTREL ON ETHINYLESTRADIOL METABOLISM, Contraception, 55(5), 1997, pp. 273-282
Citation: Rk. Hermsmeyer et al., SEX STEROID PROTECTION AGAINST CORONARY-ARTERY HYPERREACTIVITY IN RHESUS-MONKEYS, Circulation, 96(8), 1997, pp. 3372-3372
Authors:
MAKRIDAKIS N
ROSS RK
PIKE MC
CHANG L
STANCZYK FZ
KOLONEL LN
SHI CY
YU MC
HENDERSON BE
REICHARDT JKV
Citation: N. Makridakis et al., A PREVALENT MISSENSE SUBSTITUTION THAT MODULATES ACTIVITY OF PROSTATIC STEROID 5-ALPHA-REDUCTASE, Cancer research, 57(6), 1997, pp. 1020-1022
Authors:
CARMINA E
LODICO G
CAROLLO F
STANCZYK FZ
LOBO RA
Citation: E. Carmina et al., SERUM IGF-1 AND BINDING-PROTEIN-1 AND BINDING-PROTEIN-3 IN POSTMENOPAUSAL WOMEN AND THE EFFECTS OF ESTROGEN, Menopause, 3(2), 1996, pp. 85-89